AVAILABILITY OF NCI ANNOUNCEMENTS FOR FUNDING OPPORTUNITIES APPLICABLE TO
BREAST, PROSTATE, OVARIAN, AND HEAD AND NECK CANCERS
Release Date: August 23, 2000
NOTICE: CA-00-024
National Cancer Institute
The National Cancer Institute (NCI) announces the availability of web-based
information and announcements which describe current NCI funding opportunities
available to researchers interested in research in all disciplines relevant to
cancers of the breast, prostate, ovary, and head and neck. These
announcements have been developed in response to recommendations by Progress
Review Groups (PRGs) or similar types of priority setting workshops addressing
the listed cancers. Currently, the NCI has several PRGs either in various
stages of deliberations or planned. More information on PRGs is available at:
http://osp.nci.nih.gov/prg_assess/default.htm. Additional announcements will
be developed in response to recommendations from these PRGs as their reports
are completed.
The purpose of the announcements is to acquaint researchers with the diverse
opportunities supported by the NCI that either address general research themes
or are focused on disease specific questions. The NCI intends to give special
attention to research applications which address high-priority gap areas
described in the reports of these PRGs and working groups. The reports and
announcements are available on-line at:
http://cancer.gov/scienceresources/initiatives.html. Only research in the
disease sites highlighted in announcements on the website will be considered
for the purposes of this opportunity. In order to mark an application for
special consideration, investigators will be asked to cite the relevant
section(s) of the specific report and include the following language in the
Background section of their grant application: The research described in this
application is responsive to recommendations in the Report of the xxxxxxx
Cancer Progress Review Group. Do not insert this statement on the face page
of the application.
INQUIRIES:
Inquiries regarding specific NCI initiatives and grant application procedures
should be addressed to the contacts indicated in the announcement. Inquiries
regarding the Disease Specific Research Initiatives announcements or Progress
Review Groups should be addressed to:
Progress Review Group Coordinator
Office of Science Planning and Assessment
Office of the Director
National Cancer Institute
31 Center Dr., Bldg. 31, Rm. 11A03, MSC 2590
Bethesda, MD 20892-2590
Phone: 301-496-5515
FAX: 301-435-3876
E-mail: [email protected]
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
| ||||||
|
|
Department of Health and Human Services (HHS) |
|
||||
|
NIH... Turning Discovery Into Health® |
||||||